Genesis Innovation Group's Cultivate(MD) vehicle has raised $7.2m of a targeted $10m fund that will invest in early-stage healthcare technology developers.
US-based medical device developer Genesis Innovation Group has raised $7.2m for an early-stage healthcare fund called Cultivate(MD) Capital Fund with a $10m target close.
Founded in 2013, Genesis partners developers of healthcare technologies through company launches as well as seed and pre-seed investments. Cultivate(MD) will invest across the healthtech spectrum but will focus on medical device and orthopaedic technologies.
The fund is already operational and has opened diligence with multiple unspecified companies. Past recipients of Genesis funding include alloy surgical…
